Filing Flows › Vycor Medical (VYCO) › Q4 2024
Vycor Medical (VYCO) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Apr 15, 2025
Vycor Medical (VYCO) reported revenue of $455K for the fourth quarter 2024 (Q4 2024), +48% from a year earlier and +16% from the quarter before. Operating margin was 4.2%, net loss $7K (1.5% of revenue).
Vycor Medical, Q4 2024: revenue $455K (+48% year over year), operating margin 4.2%, net loss $7K, operating cash flow −$38K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $455K | +16% | +48% |
| Operating profit | $19K | — | — |
| Net earnings | −$7K | — | — |
| Operating cash flow | −$38K | — | — |
What changed
Revenue was $455K in Q4 2024, up 48% year over year and up 16% from the previous quarter. Vycor Medical was the largest line at 96% of revenue.
Gross margin was 87.3%, up 0.9 points from a year earlier. Operating profit was $19K, a 4.2% margin (up 25.0 points year over year). Operating expenses grew 14% against revenue growth of 48%. The fastest-growing cost line was Research & development (+195%). The quarter ended with a net loss of $7K, narrower than the previous quarter's $60K loss. Net interest and other expense of $26K was the main reason.
Operating cash flow was −$38K. Non-cash charges added back $15K of depreciation and amortization and $18K of share-based compensation. Working capital and other items used $65K. Capital expenditures of −$0K exceeded it, leaving free cash flow of −$38K.
Questions
What was Vycor Medical's revenue in the fourth quarter 2024?
Vycor Medical (VYCO) reported revenue of $455K for the fourth quarter 2024 (Q4 2024), +48% from a year earlier and +16% from the quarter before.
Was Vycor Medical profitable in the fourth quarter 2024?
Operating profit was $19K (4.2% of revenue) and net loss $7K.
Source: Vycor Medical 10-K on SEC EDGAR.